No Data
No Data
Press Release: Plus Therapeutics Announces Biotech Industry Veteran Kyle Guse Joins Its Board of Directors
Express News | Plus Therapeutics Announces Biotech Industry Veteran Kyle Guse Joins Its Board of Directors
12 Health Care Stocks Moving In Tuesday's Intraday Session
Plus Therapeutics Is Maintained at Buy by Ascendiant Capital
Express News | Ascendiant Capital Maintains Buy on Plus Therapeutics, Raises Price Target to $20
Retail Buyers vs. Global Sellers: Is Now the Time to Jump into U.S. Stocks?
Mimi888 : Thank you always Dr.J
105181423 : Thank you, boss.
jimmy the trader : thanks J
かつやっチョッ : Thank you, teacher
I appreciate it 